ID

31212

Descripción

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).; ODM derived from: https://clinicaltrials.gov/show/NCT00760929

Link

https://clinicaltrials.gov/show/NCT00760929

Palabras clave

  1. 29/7/18 29/7/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

29 de julio de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female patients >=18 years with histologically documented inoperable, locally advanced or metastatic (stage iiib or iv) nsclc;
Descripción

Age | Non-Small Cell Lung Carcinoma Advanced Locally Inoperable TNM clinical staging | Non-small cell lung cancer metastatic Inoperable TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C1517927
UMLS CUI [2,4]
C0205187
UMLS CUI [2,5]
C3258246
UMLS CUI [3,1]
C0278987
UMLS CUI [3,2]
C0205187
UMLS CUI [3,3]
C3258246
patients must have failed at least one but no more than two standard chemotherapy regimens;
Descripción

Chemotherapy Regimen Quantity failed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
measurable disease according to the recist criteria;
Descripción

Measurable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
ecog performance status;
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy >12 weeks.
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with active cns lesions;
Descripción

Central nervous system lesion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0742468
prior treatment with agents acting via igf-1r inhibition or egfr targeting;
Descripción

IGF1R Inhibitors | Pharmaceutical Preparations Targeting EGFR

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4044495
UMLS CUI [1,2]
C0243077
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C1521840
UMLS CUI [2,3]
C0034802
administration with high doses of systemic corticosteroids;
Descripción

CORTICOSTEROIDS FOR SYSTEMIC USE High dose

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3653708
UMLS CUI [1,2]
C0444956
radiotherapy in the 4 weeks prior to study start;
Descripción

Therapeutic radiology procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449
surgery or significant traumatic injury with in the last 2 weeks prior to study start.
Descripción

Operative Surgical Procedures | Traumatic injury

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0543467
UMLS CUI [2]
C3263723

Similar models

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00760929

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age | Non-Small Cell Lung Carcinoma Advanced Locally Inoperable TNM clinical staging | Non-small cell lung cancer metastatic Inoperable TNM clinical staging
Item
male or female patients >=18 years with histologically documented inoperable, locally advanced or metastatic (stage iiib or iv) nsclc;
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C0205187 (UMLS CUI [2,4])
C3258246 (UMLS CUI [2,5])
C0278987 (UMLS CUI [3,1])
C0205187 (UMLS CUI [3,2])
C3258246 (UMLS CUI [3,3])
Chemotherapy Regimen Quantity failed
Item
patients must have failed at least one but no more than two standard chemotherapy regimens;
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
Measurable Disease
Item
measurable disease according to the recist criteria;
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status;
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy >12 weeks.
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Central nervous system lesion
Item
patients with active cns lesions;
boolean
C0742468 (UMLS CUI [1])
IGF1R Inhibitors | Pharmaceutical Preparations Targeting EGFR
Item
prior treatment with agents acting via igf-1r inhibition or egfr targeting;
boolean
C4044495 (UMLS CUI [1,1])
C0243077 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C1521840 (UMLS CUI [2,2])
C0034802 (UMLS CUI [2,3])
CORTICOSTEROIDS FOR SYSTEMIC USE High dose
Item
administration with high doses of systemic corticosteroids;
boolean
C3653708 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
Therapeutic radiology procedure
Item
radiotherapy in the 4 weeks prior to study start;
boolean
C1522449 (UMLS CUI [1])
Operative Surgical Procedures | Traumatic injury
Item
surgery or significant traumatic injury with in the last 2 weeks prior to study start.
boolean
C0543467 (UMLS CUI [1])
C3263723 (UMLS CUI [2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial